Prevalence of markers of Hepatitis C virus among the blood donors

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 6, 2012, Pages 959-962

  Kaur, Harjot ^a   Manjari, Mridu ^a   Thaman, Richa Ghay ^a   Singh, Gagandeep ^a  

^a SRI GURU RAM DAS INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Donors; ELISA(enzyme linked immunosorbent assay); Hepatitis C; Prevalence; TTI (transfusion transmitted infection)

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BLOOD BANK; BLOOD DONOR; CONTROLLED STUDY; DISEASE MARKER; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT SAFETY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TREND STUDY;

HEPATITIS C VIRUS;

EID: 84866060619     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. F, Castelli D, Marcincola F, Dodd RY, Brander C. Transfusion-transmitted infections. Journal of Transfusion Medicine. 2007; 5:25.
2. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate and the window-period model (editorial). A National Heart, Lung and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion. 2002; 42:966-73.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW. Isolation of a c DNA clone which was derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244:359-62.
4. Barth H, Liang TJ, Baumert TF. The Hepatitis C virus entry: molecular biology and clinical implications. Hepatology. 2006;44: 527-35.
5. Thakral B, Marwaha N, Chawla Y. K, Saluja K, Sharma A, Sharma R. R, et al. The prevalence and the significance of the Hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006; 124: 431-38.
6. Sonawane BR, Birare SD, Kulkarni PV. The prevalence of seroreactivity among the blood donors in a rural population. Indian J Med Sci. 2003; 57: 405-07.
7. Virk S. Punjab leads in the Hepatitis C cases. Times of India. 2009 May 19.
8. The Government of India (1989): Drugs and Cosmetics Act. The Gazette of India. New Delhi.
9. Mukhopadhya A. Hepatitis C in India. J. Biosci. 2008; 33:465-73.
10. Garg S, Mathur DR, Garg DK. Comparison of the seropositivity of HIV, HBV, HCV and Syphilis in the replacement and the voluntary blood donors in western India. Indian J Pathol Microbiol. 2001; 44: 409-12
11. Adhikari L, Bhalla D, SharmaDC, Sharma DK, Pal R, Gupta A. Infectious disease markers among the blood donors at a central referral hospital in Gangtok, Sikkim. Asia J Transfuse Sci. 2010;4(1):41-2.
12. Bhattacharaya P, Chandra PK, Datta S, Banerjee A, Chakrarborthu S, Rajendran K, et al. A significant increase in the HBV, HCV, HIV and the Syphilis infections among the blood donors in West Bengal, eastern India 2004-2005. World Journal of Gastroenterology. 2007;19(27):3730-33.
13. Gupta PK, Kumar H, Basannar DR, Jaiprakash M. Transfusion transmitted infections in the armed forces: prevalence and trends. MJAFI. 2006; 62:348-50.
14. Bhawani Y, Rao P R, Sudhakar V. The seroprevalence of transfusion transmissible infections among the blood donors in a tertiary care hospital of Andhra Pradesh. Biology and Medicine. 2010; 2(4):45-48.
15. Gupta R, Singh B, Singh DK, Chugh M. The prevalence and the trends of transfusion transmitted infections in a regional blood transfusion centre. Asian J Transfus Sci. 2011;5(2):177-78.
16. Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and Syphilis in the blood donors in southern Harayana. Indian J Pathol Microbiol.2010;53;308-9.
17. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and Syphillis in voluntary blood donors. Indian J Med Sci. 2004; 58:255-7.
18. Pahuja S, Sharma M, Baitha B, Jain M. The prevalence and the trends of the markers of the hepatitis C virus, the hepatitis B virus and the human immunodeficiency virus in the Delhi blood donors: A hospital based study. Jpn J Infct Dis. 2007; 60; 389-91.
19. Meena M, Jindal T, Hazarika A. Prevalence of the hepatitis B virus and the hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study. Transfusion. 2001:51(1), 198-202.
20. Shakil OA, Alter JH, Hayashi P, Kleiner ED, Tedeschi V, Conjeevaram SH, et al. Volunteer blood donors with antibodies to the hepatitis C virus: Clinical, biochemical, virological and histological features. Ann Intern Med. 1995; 123:330-7.
21. Esteben JI, Lopez Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. A high rate of infectivity and liver disease in blood donors with antibodies to the hepatitis C virus. Ann Intern Med. 1991; 115:443-9.
22. Nalpas B, Romeo R, Pol S, Theirs V, Carnot F, Berthelot P, et al. The serum hepatitis C virus RNA; a reliable tool for evauating HCV related disease in ani-HCV positive blood donors with persistently normal alanine aminotransferase values. Transfusion. 1995; 35:750-3.